Eric T. Clambey

5.0k total citations
69 papers, 3.3k citations indexed

About

Eric T. Clambey is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Eric T. Clambey has authored 69 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 32 papers in Oncology and 12 papers in Epidemiology. Recurrent topics in Eric T. Clambey's work include Immune Cell Function and Interaction (26 papers), Immunotherapy and Immune Responses (17 papers) and Cancer Immunotherapy and Biomarkers (15 papers). Eric T. Clambey is often cited by papers focused on Immune Cell Function and Interaction (26 papers), Immunotherapy and Immune Responses (17 papers) and Cancer Immunotherapy and Biomarkers (15 papers). Eric T. Clambey collaborates with scholars based in United States, Netherlands and Germany. Eric T. Clambey's co-authors include Holger K. Eltzschig, Eóin N. McNamee, Joseph A. Westrich, Raphael A. Nemenoff, Dirk Homann, Philippa Marrack, John W. Kappler, Lynn E. Heasley, Bonnie Bullock and Sean P. Colgan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Eric T. Clambey

69 papers receiving 3.2k citations

Peers

Countries citing papers authored by Eric T. Clambey

Since Specialization

Citations

This map shows the geographic impact of Eric T. Clambey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric T. Clambey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric T. Clambey more than expected).

Fields of papers citing papers by Eric T. Clambey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric T. Clambey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric T. Clambey. The network helps show where Eric T. Clambey may publish in the future.

Co-authorship network of co-authors of Eric T. Clambey

This figure shows the co-authorship network connecting the top 25 collaborators of Eric T. Clambey. A scholar is included among the top collaborators of Eric T. Clambey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric T. Clambey. Eric T. Clambey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Regulation of volume-regulated anion channels alters sensitivity to platinum chemotherapy 2024 ·Science Advances ·(unknown), Saswat Mohapatra, Robert T. Jones, (unknown), (unknown), (unknown), Molishree Joshi, (unknown), (unknown), (unknown), Carlos Enrique Toro Gutiérrez, Huihui Ye, Eric T. Clambey, Sarah J. Parker, Tokameh Mahmoudi, Tahlita C.M. Zuiverloon, James C. Costello, Dan Theodorescu	1
2	Immune checkpoint activity regulates polycystic kidney disease progression 2023 ·JCI Insight ·Emily K. Kleczko, (unknown), (unknown), (unknown), (unknown), (unknown), Michael Berger, Seth B. Furgeson, Berenice Y. Gitomer, Michel B. Chonchol, Eric T. Clambey, Kurt A. Zimmerman, Raphael A. Nemenoff, Katharina Hopp	9
3	The tryptophan-metabolizing enzyme indoleamine 2,3-dioxygenase 1 regulates polycystic kidney disease progression 2022 ·JCI Insight ·(unknown), Emily K. Kleczko, Nidhi Dwivedi, (unknown), Berenice Y. Gitomer, Michel B. Chonchol, Eric T. Clambey, Raphael A. Nemenoff, Jost Klawitter, Katharina Hopp	13
4	FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC 2021 ·Clinical Cancer Research ·Thomas E. Bickett, Michael W. Knitz, Laurel B. Darragh, Shilpa Bhatia, Benjamin Van Court, Jacob Gadwa, (unknown), Miles Piper, Diemmy Nguyen, Hua Tu, Laurel Lenz, Eric T. Clambey, Kevin C. Barry, Sana D. Karam	22
5	Tolerance induction in memory CD4 T cells is partial and reversible 2020 ·Immunology ·Joshua I. Gray, (unknown), Fraser Morton, Eric T. Clambey, Laurent Gapin, Jennifer L. Matsuda, John W. Kappler, Philippa Marrack, Paul Garside, Thomas D. Otto, Megan K. L. MacLeod	4
6	Cancer cell-intrinsic expression of MHC II in lung cancer cell lines is actively restricted by MEK/ERK signaling and epigenetic mechanisms 2020 ·Journal for ImmunoTherapy of Cancer ·Alexander Neuwelt, Abigail K. Kimball, Amber M. Johnson, (unknown), Bonnie Bullock, Rachael E. Kaspar, Emily K. Kleczko, Jeff Kwak, Meng‐Han Wu, Lynn E. Heasley, Robert C. Doebele, Howard Li, Raphael A. Nemenoff, Eric T. Clambey	37
7	High-Dimensional Analysis of Postsplenectomy Peripheral Immune Cell Changes 2020 ·ImmunoHorizons ·Jessica S.W. Borgers, Richard P. Tobin, (unknown), Joshua M. Smith, Dana M. Davis, Abigail K. Kimball, Eric T. Clambey, Kasey L. Couts, Jennifer McWilliams, Kimberly R. Jordan, Robert J. Torphy, Richard D. Schulick, Martin D. McCarter	7
8	Complement factor H–deficient mice develop spontaneous hepatic tumors 2020 ·Journal of Clinical Investigation ·Jennifer Laskowski, Brandon Renner, Matthew C. Pickering, Natalie J. Serkova, Peter Smith‐Jones, Eric T. Clambey, Raphael A. Nemenoff, Joshua M. Thurman	49
9	Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide 2020 ·Cancer Immunology Immunotherapy ·Ayman Oweida, Adam C. Mueller, Miles Piper, (unknown), Benjamin Van Court, Shilpa Bhatia, Andy V. Phan, Thomas E. Bickett, Kimberly R. Jordan, Theresa A. Proia, Richard D. Schulick, Wells A. Messersmith, Marco Del Chiaro, Eric T. Clambey, Michael J. Gough, Jason S. Williams, Kirk C. Hansen, Karyn A. Goodman, Sana D. Karam	27
10	Inhibition of EphB4–Ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck Cancers 2019 ·Cancer Research ·Shilpa Bhatia, Ayman Oweida, Shelby Lennon, Laurel B. Darragh, (unknown), Andy V. Phan, Adam C. Mueller, Benjamin Van Court, David Raben, Natalie J. Serkova, Xiao‐Jing Wang, Antonio Jimeno, Eric T. Clambey, Elena B. Pasquale, Sana D. Karam	38
11	Multidimensional analysis of Gammaherpesvirus RNA expression reveals unexpected heterogeneity of gene expression 2019 ·PLoS Pathogens ·Lauren Oko, Abigail K. Kimball, Rachael E. Kaspar, (unknown), Carrie B. Coleman, Rosemary Rochford, Tim Chang, Benjamin Alderete, Linda F. van Dyk, Eric T. Clambey	7
12	Tumor-intrinsic response to IFNγ shapes the tumor microenvironment and anti–PD-1 response in NSCLC 2019 ·Life Science Alliance ·Bonnie Bullock, Abigail K. Kimball, Joanna M. Poczobutt, Alexander Neuwelt, Howard Li, Amber M. Johnson, Jeff Kwak, Emily K. Kleczko, Rachael E. Kaspar, (unknown), Katharina Hopp, Erin L. Schenk, Mary C. Weiser-Evans, Eric T. Clambey, Raphael A. Nemenoff	39
13	High-Dimensional Characterization of IL-10 Production and IL-10–Dependent Regulation during Primary Gammaherpesvirus Infection 2019 ·ImmunoHorizons ·Abigail K. Kimball, Lauren Oko, Rachael E. Kaspar, Linda F. van Dyk, Eric T. Clambey	6
14	Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration 2018 ·Clinical Cancer Research ·Ayman Oweida, Mohammad K. Hararah, Andy V. Phan, David C. Binder, Shilpa Bhatia, Shelby Lennon, Sanjana Bukkapatnam, Benjamin Van Court, (unknown), Laurel B. Darragh, H. Mike Kim, David Raben, Aik Choon Tan, Lynn E. Heasley, Eric T. Clambey, Raphael A. Nemenoff, Sana D. Karam	209
15	Complement Activation via a C3a Receptor Pathway Alters CD4+ T Lymphocytes and Mediates Lung Cancer Progression 2017 ·Cancer Research ·Jeff Kwak, Jennifer Laskowski, Howard Li, Maria McSharry, Trisha R. Sippel, Bonnie Bullock, Amber M. Johnson, Joanna M. Poczobutt, Alexander Neuwelt, Stephen P. Malkoski, Mary C. Weiser-Evans, John D. Lambris, Eric T. Clambey, Joshua M. Thurman, Raphael A. Nemenoff	103
16	The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1/PD-L1 Antibody Blockade 2017 ·Cancer Immunology Research ·Howard Li, Maria McSharry, Bonnie Bullock, Teresa T. Nguyen, Jeff Kwak, Joanna M. Poczobutt, Trisha R. Sippel, Lynn E. Heasley, Mary C. Weiser-Evans, Eric T. Clambey, Raphael A. Nemenoff	128
17	Aging promotes acquisition of naive-like CD8+ memory T cell traits and enhanced functionalities 2016 ·Journal of Clinical Investigation ·Jens Eberlein, Bennett Davenport, Tom Nguyen, Francisco Victorino, K. Haist, Kevin Jhun, Anis Karimpour‐Fard, Lawrence Hunter, Ross M. Kedl, Eric T. Clambey, Dirk Homann	18
18	Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14 2016 ·mBio ·Louis Cicchini, Joseph A. Westrich, Tao Xu, Daniel W. Vermeer, Jennifer Berger, Eric T. Clambey, Denis Lee, John I. Song, Paul F. Lambert, Robert O. Greer, John H. Lee, Dohun Pyeon	91
19	Hypoxia-inducible factor-1 alpha–dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa 2012 ·Proceedings of the National Academy of Sciences ·Eric T. Clambey, Eóin N. McNamee, Joseph A. Westrich, Louise Glover, Eric L. Campbell, Paul Jedlicka, Edwin F. de Zoeten, John C. Cambier, Kurt R. Stenmark, Sean P. Colgan, Holger K. Eltzschig	457
20	CD8 T cell clonal expansions & aging: A heterogeneous phenomenon with a common outcome 2007 ·Experimental Gerontology ·Eric T. Clambey, John W. Kappler, Philippa Marrack	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact